First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler

Ultrasound in Obstetrics and Gynecology

Volumn 43, Issue 1, 2014, Pages 34-40

  Crovetto, F ^a,b   Crispi, F ^a   Scazzocchio, E ^c   Mercade, I ^a   Meler, E ^a,c   Figueras, F ^a   Gratacos, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

first trimester; pre eclampsia; screening; small for gestational age; uterine artery Doppler

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; DOPPLER ECHOGRAPHY; ECHOGRAPHY; EVALUATION STUDY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GROWTH, DEVELOPMENT AND AGING; HUMAN; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PROSPECTIVE STUDY; PULSATILE FLOW; SCREENING; SMALL FOR DATE INFANT; SMALL-FOR-GESTATIONAL AGE; UTERINE ARTERY; UTERINE ARTERY DOPPLER;

FIRST TRIMESTER; PRE-ECLAMPSIA; SCREENING; SMALL-FOR-GESTATIONAL AGE; UTERINE ARTERY DOPPLER;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; PULSATILE FLOW; ULTRASONOGRAPHY, DOPPLER, PULSED; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY;

EID: 84891824326     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.12537     Document Type: Article

References (42)

1. McIntire DD, Bloom SL, Casey BM, Leveno KJ,. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340: 1234-1238.
2. Breeze AC, Lees CC,. Prediction and perinatal outcomes of fetal growth restriction. Semin Fetal Neonatal Med 2007; 12: 383-397.
3. Figueras F, Oros D, Cruz-Martinez R, Padilla N, Hernandez-Andrade E, Botet F, Costas-Moragas C, Gratacos E,. Neurobehavior in term, small-for-gestational age infants with normal placental function. Pediatrics 2009; 124: e934-941.
4. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS,. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938-941.
5. Crispi F, Bijnens B, Figueras F, Bartrons J, Eixarch E, Le Noble F, Ahmed A, Gratacõs E,. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation 2010; 121: 2427-2436.
6. Lindqvist PG, Molin J,. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005; 25: 258-264.
7. Figueras F, Gardosi J,. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol 2011; 204: 288-300.
8. Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguère Y,. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 2009; 31: 818-826.
9. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH,. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 583-586.
10. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM,. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762-1767.
11. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R,; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004; 191: 1452-1458.
12. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH,. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005; 25: 949-953.
13. Dugoff L, Lynch AM, Cioffi-Ragan D, Hobbins JC, Schultz LK, Malone FD, D'Alton ME,; FASTER Trial Research Consortium. First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction. Am J Obstet Gynecol 2005; 193: 1208-1212.
14. Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A,. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol 2007; 29: 135-140.
15. Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH,. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008; 31: 15-19.
16. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH,. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008; 28: 1110-1115.
17. Melchiorre K, Leslie K, Prefumo F, Bhide A, Thilaganathan B,. First-trimester uterine artery Doppler indices in the prediction of small-for-gestational age pregnancy and intrauterine growth restriction. Ultrasound Obstet Gynecol 2009; 33: 524-529.
18. Law LW, Leung TY, Sahota DS, Chan LW, Fung TY, Lau TK,. Which ultrasound or biochemical markers are independent predictors of small-for-gestational age? Ultrasound Obstet Gynecol 2009; 34: 283-287.
19. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH,. Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates. Prenat Diagn 2011; 31: 58-65.
20. Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH,. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks. Fetal Diagn Ther 2011; 29: 148-154.
21. Nanda S, Akolekar R, Sodre D, Vaikousi E, Nicolaides KH,. Maternal serum adiponectin at 11-13 weeks of gestation in pregnancies delivering small for gestation neonates. Fetal Diagn Ther 2011; 29: 274-279.
22. Hui D, Okun N, Murphy K, Kingdom J, Uleryk E, Shah PS,. Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review. J Obstet Gynaecol Can 2012; 34: 142-153.
23. Papastefanou I, Souka AP, Pilalis A, Eleftheriades M, Michalitsi V, Kassanos D,. First trimester prediction of small- and large-for-gestation neonates by an integrated model incorporating ultrasound parameters, biochemical indices and maternal characteristics. Acta Obstet Gynecol Scand 2012; 91: 104-111.
24. Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacõs E,. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31: 303-309.
25. Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, Germer U, Moyano D, Turan S, Hartung J, Bhide A, Müller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR,. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007; 109: 253-261.
26. Gardosi J, Kady SM, McGeown P, Francis A, Tonks A,. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005; 331: 1113-1117.
27. Cruz-Martinez R, Figueras F, Oros D, Padilla N, Meler E, Hernandez-Andrade E, Gratacos E,. Cerebral blood perfusion and neurobehavioral performance in full-term small-for-gestational-age fetuses. Am J Obstet Gynecol 2009; 201: 474.e1-7.
28. Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH,. Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagn Ther 2013; 33: 16-27.
29. Robinson HP, Sweet EM, Adam AH,. The accuracy of radiological estimates of gestational age using early fetal crown-rump length measurements by ultrasound as a basis for comparison. Br J Obstet Gynaecol 1979; 86: 525-528.
30. Casals E, Aibar C, Martinez JM, Borrell A, Soler A, Ojuel J, Ballesta AM, Fortuny A,. First-trimester biochemical markers for Down syndrome. Prenat Diagn 1999; 19: 8-11.
31. Gomez O, Martinez JM, Figueras F, Del Río M, Borobio V, Puerto B, Coll O, Cararach V, Vanrell JA,. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 2005; 26: 490-494.
32. Figueras F, Meler E, Iraola A, Eixarch E, Coll O, Figueras J, Francis A, Gratacos E, Gardosi J,. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol 2008; 136: 20-24.
33. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM,. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX-XIV.
34. Scazzocchio E, Figueras F, Crispi F, Meler E, Masoller N, Mula R, Gratacos E,. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. Am J Obstet Gynecol 2013; 208: 203.e1-10.
35. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH,. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011; 31: 66-74.
36. Crispi F, Domínguez C, Llurba E, Martín-Gallán P, Cabero L, Gratacõs E,. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006; 195: 201-207.
37. Souka AP, Papastefanou I, Pilalis A, Michalitsi V, Kassanos D,. Performance of third-trimester ultrasound for prediction of small-for- gestational-age neonates and evaluation of contingency screening policies. Ultrasound Obstet Gynecol 2012; 39: 535-542.
38. Crispi F, Figueras F, Cruz-Lemini M, Bartrons J, Bijnens B, Gratacos E,. Cardiovascular programming in children born small for gestational age and relationship with prenatal signs of severity. Am J Obstet Gynecol 2012; 207: 121.e1-9.
39. American College of Obstetricians and Gynecologists. ACOG practice bulletin No 12: clinical management guidelines for obstetrician-gynecologists. Intrauterine growth restriction. ACOG: Washington, DC, 2000.
40. Royal College of Obstetricians and Gynaecologists. Green-top guide No.31. Small-for-Gestatational-Age fetus, Investigation and Management. Royal College of Obstetricians and Gynecologists: London, UK, 2002.
41. Altman DG, Vergouwe Y, Royston P, Moons KG,. Prognosis and prognostic research: validating a prognostic model. BMJ 2009; 338: 1432-1435.
42. Borrell A, Casals E, Fortuny A, Farre MT, Gonce A, Sanchez A, Soler A, Cararach V, Vanrell JA,. First-trimester screening for trisomy 21 combining biochemestry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn 2004; 24: 541-545.